Compounds > cidofovir anhydrous

Page last updated: 2024-08-24

cidofovir anhydrous and Epidermodysplasia Verruciformis

cidofovir anhydrous has been researched along with Epidermodysplasia Verruciformis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Moore, S; Rady, P; Tyring, S	1
Alsina-Gibert, M; Cañadas, MP; Darwich, E; Darwich, L; Ercilla, G; Klaustermeier, J; Mascaró, JM	1
Kreuter, A; Potthoff, A; Wieland, U	1
Brink, NS; Groves, RW; Kapur, N; Preiser, W; Snoeck, R	1

Reviews

1 review(s) available for cidofovir anhydrous and Epidermodysplasia Verruciformis

Article	Year
Acquired epidermodysplasia verruciformis: clinical presentation and treatment update. International journal of dermatology, 2022, Volume: 61, Issue:11 Topics: Acitretin; Cidofovir; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Mycophenolic Acid; Papillomaviridae; Papillomavirus Infections; Vaccines	2022

Other Studies

3 other study(ies) available for cidofovir anhydrous and Epidermodysplasia Verruciformis

Article	Year
New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir. Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:2 Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Epidermodysplasia Verruciformis; Follow-Up Studies; Humans; Male; Middle Aged; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Sampling Studies; Severity of Illness Index; Treatment Outcome	2011
Failure of intravenous cidofovir for generalized verrucosis in a patient with severe combined immunodeficiency. Archives of dermatology, 2012, Volume: 148, Issue:5 Topics: Antiviral Agents; Cidofovir; Cytosine; Epidermodysplasia Verruciformis; Follow-Up Studies; Humans; Male; Organophosphonates; Severe Combined Immunodeficiency; Treatment Failure; Young Adult	2012
No apparent effect of cidofovir in epidermodysplasia verruciformis. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2000, Volume: 16, Issue:1 Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Epidermodysplasia Verruciformis; Humans; Male; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Treatment Failure	2000